Head and Neck Cancer
CAMPEP Credits: 0.50
MDCB Credits: 0.50
Please find the details of each abstract that will be highlighted in this session below:
Abstract #: 315Title: HPV-Seq Is Prognostic in p16-Positive Oropharyngeal Cancer (OPC): Independent Validation in a Large Prospective Cohort and a Secondary Analysis of NRG-HN002Presenting Author: Eric Yang Stutheit-Zhao, MD, PhD
Abstract #: 313Title: Quality of Life (QOL) of Patients with Human Papillomavirus (HPV)-Associated Oropharyngeal Squamous Cell Carcinoma (OPSCC) in NRG-HN002Presenting Author: Minh Tam Truong, MD, MBA, MBBS, FASTRO
Abstract #: 314Title: HYHOPE: A Phase I Study of De-intensified Hypofractionated Radiation Therapy for Human Papillomavirus-Associated Oropharynx CancerPresenting Author: Dominic H. Moon, MD
Abstract #: 3725Title: Global Interobserver Variations of Clinical Target Volume (CTV) Delineation Among International Experts in Predefined Gross Tumor Volume (GTV) and Organs at Risk (OAR) Volumes in Head and Neck CancerPresenting Author: Ugur Selek, MD, FASTRO, Prof.
Abstract #: 143Title: Contralateral Neck Recurrence Rates in Head and Neck Carcinomas After Primary Surgery, Bilateral Neck Dissection, a Pathologically Negative Contralateral Neck, and Adjuvant Ipsilateral Neck RadiationPresenting Author: Kendall Kiser, MD, MS
Abstract #: 145Title: Acupuncture for (Chemo)Radiotherapy-Related Dysphagia in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC): A Randomized Phase 2 StudyPresenting Author: Pierluigi Bonomo, MD
Discussant: Michelle Mierzwa, MD – University of Michigan